Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (2047)
NICE advice (319)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (227)
COVID-19 rapid guidelines (8)
Diagnostics guidance (52)
Early value assessment (30)
HealthTech guidance (773)
Highly specialised technologies guidance (30)
Interventional procedures guidance (617)
Late stage assessment (8)
Medical technologies guidance (66)
Medicines practice guidelines (5)
NICE guidelines (336)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (906)
HealthTech approach
HealthTech approach
Early use (30)
Existing use (8)
Interventional procedure (617)
Routine use (118)
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (7)
Apply filters
Showing 801 to 825 of 2047
Sort by
Date
Title
Apply sorting
Type: Guidance
`Remove $Type: Guidance filter`
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)
TA702
26 May 2021
26 May 2021
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)
TA703
26 May 2021
26 May 2021
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies
TA704
26 May 2021
26 May 2021
Heavy menstrual bleeding: assessment and management
NG88
14 March 2018
24 May 2021
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography
HTG429
13 February 2017
19 May 2021
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
HTG355
12 November 2014
19 May 2021
Ravulizumab for treating paroxysmal nocturnal haemoglobinuria
TA698
19 May 2021
19 May 2021
Ofatumumab for treating relapsing multiple sclerosis
TA699
19 May 2021
19 May 2021
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)
TA701
19 May 2021
19 May 2021
Permanent His-bundle pacemaker implantation for treating heart failure
HTG579
5 May 2021
5 May 2021
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
HTG578
4 May 2021
4 May 2021
Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma
HTG576
28 April 2021
28 April 2021
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults
HTG577
28 April 2021
28 April 2021
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
TA692
28 April 2021
28 April 2021
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
TA694
28 April 2021
28 April 2021
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma
TA695
28 April 2021
28 April 2021
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver
HTG575
21 April 2021
21 April 2021
Acalabrutinib for treating chronic lymphocytic leukaemia
TA689
21 April 2021
21 April 2021
Avelumab for untreated metastatic Merkel cell carcinoma
TA691
21 April 2021
21 April 2021
Avelumab for treating metastatic Merkel cell carcinoma
TA517
11 April 2018
21 April 2021
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain
NG193
7 April 2021
7 April 2021
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids
HTG572
31 March 2021
31 March 2021
Extracorporeal whole liver perfusion for acute liver failure
HTG573
31 March 2021
31 March 2021
Danis stent for acute oesophageal variceal bleeding
HTG574
31 March 2021
31 March 2021
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA687
31 March 2021
31 March 2021
Previous page
1
…
31
32
Current page
33
34
35
…
82
Page
33
of
82
Next page
Results per page
10
25
50
All
Back to top